Indoleamine 2,3-dioxygenase, immunosuppression and pregnancy

Andrew L. Mellor, Phillip Chandler, Geon Kook Lee, Theodore Johnson, Derin B. Keskin, Jeffrey Lee, David H. Munn

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

Pharmacologic inhibition of indoleamine 2,3-dioxygenase (IDO) activity during murine pregnancy results in maternal T-cell-mediated rejection of allogeneic but not syngeneic conceptuses. Increased risk of allogeneic pregnancy failure induced by exposure to IDO inhibitor is strongly correlated with maternal C3 deposition at the maternal-fetal interface. Here we review evidence that cells expressing IDO contribute to immunosuppression by inhibiting T-cell responses to tumor antigens and tissue allografts, as well as fetal tissues.

Original languageEnglish (US)
Pages (from-to)143-150
Number of pages8
JournalJournal of Reproductive Immunology
Volume57
Issue number1-2
DOIs
StatePublished - Oct 31 2002

Fingerprint

Indoleamine-Pyrrole 2,3,-Dioxygenase
Immunosuppression
Mothers
Pregnancy
T-Lymphocytes
Neoplasm Antigens
Allografts
Fetus

Keywords

  • Immunosuppression
  • Indoleamine 2,3-dioxygenase
  • Pregnancy

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

Indoleamine 2,3-dioxygenase, immunosuppression and pregnancy. / Mellor, Andrew L.; Chandler, Phillip; Lee, Geon Kook; Johnson, Theodore; Keskin, Derin B.; Lee, Jeffrey; Munn, David H.

In: Journal of Reproductive Immunology, Vol. 57, No. 1-2, 31.10.2002, p. 143-150.

Research output: Contribution to journalArticle

Mellor, Andrew L. ; Chandler, Phillip ; Lee, Geon Kook ; Johnson, Theodore ; Keskin, Derin B. ; Lee, Jeffrey ; Munn, David H. / Indoleamine 2,3-dioxygenase, immunosuppression and pregnancy. In: Journal of Reproductive Immunology. 2002 ; Vol. 57, No. 1-2. pp. 143-150.
@article{514ea8abd3754ad68bdab2f5dd1bb074,
title = "Indoleamine 2,3-dioxygenase, immunosuppression and pregnancy",
abstract = "Pharmacologic inhibition of indoleamine 2,3-dioxygenase (IDO) activity during murine pregnancy results in maternal T-cell-mediated rejection of allogeneic but not syngeneic conceptuses. Increased risk of allogeneic pregnancy failure induced by exposure to IDO inhibitor is strongly correlated with maternal C3 deposition at the maternal-fetal interface. Here we review evidence that cells expressing IDO contribute to immunosuppression by inhibiting T-cell responses to tumor antigens and tissue allografts, as well as fetal tissues.",
keywords = "Immunosuppression, Indoleamine 2,3-dioxygenase, Pregnancy",
author = "Mellor, {Andrew L.} and Phillip Chandler and Lee, {Geon Kook} and Theodore Johnson and Keskin, {Derin B.} and Jeffrey Lee and Munn, {David H.}",
year = "2002",
month = "10",
day = "31",
doi = "10.1016/S0165-0378(02)00040-2",
language = "English (US)",
volume = "57",
pages = "143--150",
journal = "Journal of Reproductive Immunology",
issn = "0165-0378",
publisher = "Elsevier Ireland Ltd",
number = "1-2",

}

TY - JOUR

T1 - Indoleamine 2,3-dioxygenase, immunosuppression and pregnancy

AU - Mellor, Andrew L.

AU - Chandler, Phillip

AU - Lee, Geon Kook

AU - Johnson, Theodore

AU - Keskin, Derin B.

AU - Lee, Jeffrey

AU - Munn, David H.

PY - 2002/10/31

Y1 - 2002/10/31

N2 - Pharmacologic inhibition of indoleamine 2,3-dioxygenase (IDO) activity during murine pregnancy results in maternal T-cell-mediated rejection of allogeneic but not syngeneic conceptuses. Increased risk of allogeneic pregnancy failure induced by exposure to IDO inhibitor is strongly correlated with maternal C3 deposition at the maternal-fetal interface. Here we review evidence that cells expressing IDO contribute to immunosuppression by inhibiting T-cell responses to tumor antigens and tissue allografts, as well as fetal tissues.

AB - Pharmacologic inhibition of indoleamine 2,3-dioxygenase (IDO) activity during murine pregnancy results in maternal T-cell-mediated rejection of allogeneic but not syngeneic conceptuses. Increased risk of allogeneic pregnancy failure induced by exposure to IDO inhibitor is strongly correlated with maternal C3 deposition at the maternal-fetal interface. Here we review evidence that cells expressing IDO contribute to immunosuppression by inhibiting T-cell responses to tumor antigens and tissue allografts, as well as fetal tissues.

KW - Immunosuppression

KW - Indoleamine 2,3-dioxygenase

KW - Pregnancy

UR - http://www.scopus.com/inward/record.url?scp=0037206423&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037206423&partnerID=8YFLogxK

U2 - 10.1016/S0165-0378(02)00040-2

DO - 10.1016/S0165-0378(02)00040-2

M3 - Article

C2 - 12385839

AN - SCOPUS:0037206423

VL - 57

SP - 143

EP - 150

JO - Journal of Reproductive Immunology

JF - Journal of Reproductive Immunology

SN - 0165-0378

IS - 1-2

ER -